EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSES IN TUMOR AND PLASMA SAMPLES FROM A PHASE IV, SINGLE-ARM STUDY OF FIRST-LINE GEFITINIB IN CAUCASIAN PATIENTS WITH EGFR MUTATION-POSITIVE, ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)

被引：0

作者：

Douillard, Jean-Yves ^{[1
]}

Ostoros, Gyula ^{[2
]}

Cobo, Manuel ^{[3
]}

Ciuleanu, Tudor ^{[4
]}

Mccormack, Rose ^{[7
]}

Webster, Alan ^{[5
]}

Milenkova, Tsveta ^{[6
]}

机构：

[1] Ico R Gauducheau, St Herblain, France

[2] Koranyi Natl Inst Tb & Pulmonol, Budapest, Hungary

[3] Hru Carlos Haya, Malaga, Spain

[4] Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca, Romania

[5] Astrazeneca, Biometr & Informat Sci, Cambridge, England

[6] Astrazeneca, Res & Dev, Cambridge, England

[7] Astrazeneca, Personalised Healthcare, Luton, Beds, England

来源：

关键词：

EGFR mutation; gefitinib; NSCLC; Caucasian; circulating-free DNA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.11-020

引用

页码：S1194 / S1195

页数：2